JB Chemicals & Pharmaceuticals Limited

rs,

ironment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company

14%

Views on Q3 FY25 business performance 4 Results Overview: Q3 and 9M FY25 Revenues (INR crores) 14% 845 963 13% 2,969 2,622 ◼ JB Pharma registered revenue of INR 963 crores in Q3 FY25 (YoY gro

13%

5 business performance 4 Results Overview: Q3 and 9M FY25 Revenues (INR crores) 14% 845 963 13% 2,969 2,622 ◼ JB Pharma registered revenue of INR 963 crores in Q3 FY25 (YoY growth of 14%) and

INR 963 crore

9M FY25 Revenues (INR crores) 14% 845 963 13% 2,969 2,622 ◼ JB Pharma registered revenue of INR 963 crores in Q3 FY25 (YoY growth of 14%) and INR 2969 crores in 9M FY25 (YoY growth of 13%) ◼ Domestic fo

INR 2969 crore

2,969 2,622 ◼ JB Pharma registered revenue of INR 963 crores in Q3 FY25 (YoY growth of 14%) and INR 2969 crores in 9M FY25 (YoY growth of 13%) ◼ Domestic formulations business recorded revenue of INR 566 cr

INR 566 crore

R 2969 crores in 9M FY25 (YoY growth of 13%) ◼ Domestic formulations business recorded revenue of INR 566 crores vs INR 462 crores (YoY growth of 22%) ◼ JB Pharma continues to remain one of the fastest growin

INR 462 crore

FY25 (YoY growth of 13%) ◼ Domestic formulations business recorded revenue of INR 566 crores vs INR 462 crores (YoY growth of 22%) ◼ JB Pharma continues to remain one of the fastest growing companies in the

22%

omestic formulations business recorded revenue of INR 566 crores vs INR 462 crores (YoY growth of 22%) ◼ JB Pharma continues to remain one of the fastest growing companies in the industry Q3 FY24

318 crore

f the fastest growing companies in the industry Q3 FY24 Q3 FY25 9M FY24 9M FY25 25 118 57 318 crores vs INR 383 crores ◼ International business revenue grew by 4% at INR 397 Q3 FY25 566 845 9M

INR 383 crore

growing companies in the industry Q3 FY24 Q3 FY25 9M FY24 9M FY25 25 118 57 318 crores vs INR 383 crores ◼ International business revenue grew by 4% at INR 397 Q3 FY25 566 845 9M FY25 1,749 254

4%

Y24 9M FY25 25 118 57 318 crores vs INR 383 crores ◼ International business revenue grew by 4% at INR 397 Q3 FY25 566 845 9M FY25 1,749 254 Domestic Formulations International Formulati

INR 397

M FY25 25 118 57 318 crores vs INR 383 crores ◼ International business revenue grew by 4% at INR 397 Q3 FY25 566 845 9M FY25 1,749 254 Domestic Formulations International Formulations CDMO API